Skip to content

Clinical trials

Cognitive Dysfunction trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: United Kingdom Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20092
20104
20122
20133
20145
20155
20163
20178
20189
201910
20207
202112
202214
202311
202410
202516
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Recruiting20
Unknown status15
Active, not recruiting14
Terminated10
Not yet recruiting6
Enrolling by invitation3
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London6
King's College London6
University of Nottingham6
Novoic Limited5
University of Leicester5
University of Oxford5
University of Edinburgh4
Eli Lilly and Company3
GlaxoSmithKline3
University College, London3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction127
Dementia41
Alzheimer Disease36
Stroke10
Disease6
Brain Diseases5
Mental Disorders5
Nervous System Diseases5
Neurodegenerative Diseases5
Anxiety Disorders4

Trials

Showing 1 to 25 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.